Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 391797, 14 pages
http://dx.doi.org/10.1155/2015/391797
Review Article

Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients

1Department of Nephrology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, Netherlands
2Department of Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, Netherlands

Received 28 April 2015; Accepted 26 May 2015

Academic Editor: Bjarne K. Møller

Copyright © 2015 J. R. Bank et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

J. R. Bank, T. J. Rabelink, J. W. de Fijter, and M. E. J. Reinders, “Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients,” Journal of Immunology Research, vol. 2015, Article ID 391797, 14 pages, 2015. https://doi.org/10.1155/2015/391797.